HAEMONETICS CORP Quarterly Depreciation in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Haemonetics Corp quarterly/annual Depreciation history and growth rate from Q2 2022 to Q3 2024.
  • Haemonetics Corp Depreciation for the quarter ending September 28, 2024 was $15M, a 10.3% increase year-over-year.
  • Haemonetics Corp Depreciation for the twelve months ending September 28, 2024 was $58.5M, a 9.35% increase year-over-year.
  • Haemonetics Corp annual Depreciation for 2023 was $55.8M, a 8.98% increase from 2022.
  • Haemonetics Corp annual Depreciation for 2022 was $51.2M, a 15.3% increase from 2021.
  • Haemonetics Corp annual Depreciation for 2021 was $44.4M, a 3.02% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $58.5M $15M +$1.4M +10.3% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-07
Q2 2024 $57.1M $14.6M +$1.3M +9.77% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $55.8M $14.7M +$1.2M +8.89% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 $54.6M $14.2M +$1.1M +8.4% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $53.5M $13.6M +$700K +5.43% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $52.8M $13.3M +$1.6M +13.7% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 $51.2M $13.5M Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 $13.1M Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $12.9M Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-02
Q2 2022 $11.7M Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.